Nuzenio

Ipsen

Ipsen news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 15:38:43 GMTMarengo nominates first TriSTAR candidate under USD 1.2b Ipsen collaboration - AllSci
Wed, 05 Aug 2026 07:44:36 GMTFrom molecule to medicine: the process behind patient-ready treatments - Ipsen
Tue, 04 Aug 2026 11:00:00 GMTMarengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion - Yahoo Finance
Mon, 03 Aug 2026 16:12:47 GMTIpsen bought back shares on July 27, 28 and 31, 2026 - Stock Titan
Mon, 03 Aug 2026 16:00:00 GMTIPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026 - Yahoo Finance
Mon, 03 Aug 2026 15:51:30 GMTIpsen quietly returns cancer drug IPN01194 to AGV Discovery - European Biotechnology Magazine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ipsen.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.